The Morrison Government recently announced $7 million for ground-breaking research into the use of pharmacogenomics to improve mental health treatment outcomes and help reduce suicide.
This investment, through the Medical Research
Futures Fund, will support research that aims to improve or develop new
pharmacogenomic tests that will change how medications are prescribed for
patients with mental health challenges.
The round will encourage research that combines new
and existing technologies with large scale data, machine learning, clinical
information or patient biomarkers, to result in better medication selection for
Guidelines will be released in the near future.